Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Lidocaine for Recovery Following Colorectal ESD
NCT05750056Phase 4Completed
- Sponsor
- Fujian Provincial Hospital
- Start
- Feb 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative recovery, sponsored by Fujian Provincial Hospital. Started Feb 2023; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative recovery
Beyond the preview
Go deeper on NCT05750056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05750056.